Figure 5.
Reversion of EPC increase by blocking antibodies. Use of anti-α4 (A) and anti-α5 (B) blocking antibodies inhibited SDF-1–mediated EPC increase onto FN. *P < .05; n = 3. Error bars indicate standard errors.
Reversion of EPC increase by blocking antibodies. Use of anti-α4 (A) and anti-α5 (B) blocking antibodies inhibited SDF-1–mediated EPC increase onto FN. *P < .05; n = 3. Error bars indicate standard errors.
